PharVision Advisers’s 3M MMM Stock Holding History

PharVision Advisers’s Portfolio MMM Stock Details MMM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,884	Closed	-$292K	–	890
2025 Q3	$292K	Buy	+1,884	New	+$290K	0.16%	236

Other funds holding MMM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

PharVision Advisers's MMM Position: Q4 2025 in Review

PharVision Advisers sold out of 3M (MMM) in Q4 2025, closing a stake of 1,884 shares — an estimated $292K sold.

PharVision Advisers first reported a position in MMM in Q3 2025 and held it in 1 quarter. The position peaked at $292K in Q3 2025. 2,263 funds tracked by Wall St. Rank hold MMM as of Q4 2025.

PharVision Advisers reported no remaining 3M position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 1,884 3M shares in Q4 2025, an estimated $292K.
PharVision Advisers first reported a position in 3M in Q3 2025 and held it in 1 quarter.
PharVision Advisers's 3M position peaked at $292K in Q3 2025.
2,263 funds tracked by Wall St. Rank held 3M as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.